ArticleMethodsX2025
Hybrid genetic algorithms-driven optimization of machine learning models for heart disease prediction.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning (ML) models, such as K-Nearest Neighbor (KNN) and Support Vector Machine (SVM), play a vital role in predicting heart disease. However, their performance is often limited by poor hyperparameter selection. This study presents a novel hybrid approach that uses a Genetic Algorithm (GA) to systematically optimize the hyperparameters of KNN and SVM models, leading to improved classification outcomes. The optimization driven by the GA resulted in significant performance improvements, increasing the classification accuracy of KNN to 95.38 % and SVM to 90 %. Furthermore, there were significant improvements in precision, recall, and F-score. Our findings demonstrate that GA-based hyperparameter tuning is an effective strategy for improving the predictive power and clinical relevance of ML models used for heart disease classification.•
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.